17.3 Class II: Beta Adrenergic Blockers
3 min read•june 18, 2024
Beta-blockers are key players in treating heart rhythm problems. They work by slowing down the heart and reducing its workload, which can help control irregular heartbeats and improve blood flow.
These meds block the effects of stress hormones on the heart. This makes them useful for various heart rhythm issues, from fast heartbeats to more complex arrhythmias. Nurses need to know how they work and what to watch for.
Beta-Adrenergic Blockers in Dysrhythmia Treatment
The Adrenergic System and Beta-Blockers
Top images from around the web for The Adrenergic System and Beta-Blockers
PharmacologyDEH-28Classof2011 - Cardiovascular Drugs View original
Is this image relevant?
Frontiers | Beta-Adrenergic Blockade in Critical Illness View original
Is this image relevant?
Adrenergic receptor - Wikipedia View original
Is this image relevant?
PharmacologyDEH-28Classof2011 - Cardiovascular Drugs View original
Is this image relevant?
Frontiers | Beta-Adrenergic Blockade in Critical Illness View original
Is this image relevant?
1 of 3
Top images from around the web for The Adrenergic System and Beta-Blockers
PharmacologyDEH-28Classof2011 - Cardiovascular Drugs View original
Is this image relevant?
Frontiers | Beta-Adrenergic Blockade in Critical Illness View original
Is this image relevant?
Adrenergic receptor - Wikipedia View original
Is this image relevant?
PharmacologyDEH-28Classof2011 - Cardiovascular Drugs View original
Is this image relevant?
Frontiers | Beta-Adrenergic Blockade in Critical Illness View original
Is this image relevant?
1 of 3
- Beta-blockers work by inhibiting the effects of the on
- This system plays a crucial role in regulating heart rate and contractility
- Beta-blockers exert their effects through:
- (slowing heart rate)
- (reducing contractility)
- (slowing conduction velocity)
Features of beta-adrenergic blockers
- target primarily cardiac tissue (, , )
- affect both cardiac and peripheral tissues (, nadolol)
- Reduce heart rate, contractility, and conduction velocity leading to decreased oxygen demand and improved blood flow to the heart
- Possess by suppressing and slowing ventricular response in and flutter
Mechanism and effects of beta-blockers
- Competitively block resulting in decreased of the heart
- Prolong refractory period of and reduce automaticity of ectopic pacemakers
- Indicated for treating (SVT), (VT), atrial fibrillation and flutter with rapid ventricular response, and
- Potential side effects include:
- and
- and
- in patients with asthma or COPD
- Masking symptoms of hypoglycemia in diabetic patients
Nursing considerations for beta-blockers
- Assess baseline , especially heart rate and blood pressure, before administering medication
- Monitor for changes in rhythm and heart rate to evaluate effectiveness and detect potential complications
- Administer medication as prescribed, typically orally or intravenously, and observe for signs of , hypotension, or
- Assess lung sounds for or , particularly in patients with respiratory conditions, to identify potential bronchospasm
- Monitor in diabetic patients as beta-blockers may mask symptoms of hypoglycemia
- Educate patients on the importance of taking medication as prescribed and reporting side effects to ensure adherence and early detection of adverse reactions
Patient education for beta-blockers
- Explain the purpose and expected benefits of beta-blocker therapy in controlling abnormal heart rhythms and reducing symptoms such as or chest discomfort
- Discuss common side effects (dizziness, fatigue, ) and when to report them to the healthcare provider (difficulty breathing, wheezing, slow heart rate, fainting)
- Emphasize the importance of taking medication as prescribed and not stopping or changing dosage without consulting the healthcare provider
- Advise on what to do in case of a missed dose to maintain consistent therapeutic levels
- Encourage regular follow-up appointments to monitor therapy effectiveness and side effects for optimal management
- Provide written materials or resources for additional information and support to enhance patient understanding and engagement in their care
Key Terms to Review (48)
Adrenergic System: The adrenergic system, also known as the sympathetic nervous system, is a division of the autonomic nervous system that is responsible for the body's physiological responses to stress and emergency situations. It plays a crucial role in regulating various bodily functions, including heart rate, blood pressure, breathing, and metabolism.
Antiarrhythmic Properties: Antiarrhythmic properties refer to the ability of certain medications to regulate and stabilize the heart's electrical activity, preventing or managing abnormal heart rhythms, known as arrhythmias. These properties are particularly important in the context of Class II beta-adrenergic blockers, which are a category of antiarrhythmic drugs.
Atenolol: Atenolol is a cardioselective beta-blocker medication primarily used to treat high blood pressure, angina, and certain heart rhythm disorders. It works by selectively blocking beta-1 adrenergic receptors, which are predominantly found in the heart, reducing the heart's workload and oxygen demand.
Atrial Fibrillation: Atrial fibrillation is an irregular and often rapid heart rate that can increase the risk of stroke, heart failure, and other heart-related complications. It occurs when the upper chambers of the heart (the atria) quiver instead of beating effectively, leading to an irregular and sometimes rapid heartbeat.
Atrial fibrillation with rapid ventricular response: Atrial fibrillation with rapid ventricular response (AFib with RVR) is a condition where the atria beat irregularly and frequently, leading to a fast heart rate in the ventricles. This can result in poor blood flow and increased risk of stroke.
Atrial Flutter: Atrial flutter is a type of cardiac arrhythmia characterized by a rapid, regular, and organized electrical activity in the atria of the heart. It is a common dysrhythmia that is closely related to the topics of introduction to dysrhythmias, as well as the various antiarrhythmic drug classes covered in this chapter.
AV node: The atrioventricular (AV) node is a critical component of the heart's electrical conduction system, responsible for coordinating the contraction of the atria and ventricles. It serves as a relay station, receiving electrical impulses from the atria and transmitting them to the ventricles, ensuring the proper timing and sequence of heart contractions.
Beta blocker: Beta blockers are medications that reduce blood pressure by blocking the effects of adrenaline on beta receptors. They are commonly used to manage cardiac conditions such as hypertension, arrhythmias, and heart failure.
Beta Receptors: Beta receptors are a type of adrenergic receptor found primarily in the cardiovascular system, smooth muscle, and metabolic tissues. They play a crucial role in mediating the physiological effects of the neurotransmitter norepinephrine and the hormone epinephrine, which are part of the sympathetic nervous system.
Beta-adrenergic blockers: Beta-adrenergic blockers, also known as beta-blockers, are medications that reduce blood pressure by blocking the effects of adrenaline on beta receptors in the heart and blood vessels. They are used to treat various cardiovascular conditions including hypertension, angina, and dysrhythmias.
Beta-Adrenergic Receptors: Beta-adrenergic receptors are a class of G protein-coupled receptors that bind to the neurotransmitter norepinephrine and the hormone epinephrine. These receptors play a crucial role in the sympathetic nervous system's regulation of various physiological processes, including heart rate, blood pressure, and metabolic functions.
Bisoprolol: Bisoprolol is a beta-adrenergic blocker primarily used to manage hypertension and heart failure. It works by inhibiting the action of certain natural chemicals in the body, like epinephrine, on the heart and blood vessels.
Blood Glucose Levels: Blood glucose levels refer to the concentration of glucose, the primary source of energy for the body's cells, circulating in the bloodstream. Maintaining proper blood glucose levels is crucial for overall health, particularly in the context of Class II: Beta Adrenergic Blockers.
Bradycardia: Bradycardia is a slower than normal heart rate, typically defined as fewer than 60 beats per minute in adults. It can be a sign of an underlying health issue or a side effect of certain medications.
Bradycardia: Bradycardia is a condition characterized by an abnormally slow heart rate, typically less than 60 beats per minute. This term is relevant in the context of various cardiovascular and pharmacological topics, as it can be a side effect or complication associated with certain medications and disease states.
Brevibloc: Brevibloc, also known as esmolol, is a short-acting beta-1 adrenergic blocker used to manage acute supraventricular tachycardia and control heart rate. It reduces cardiac output by decreasing the heart rate and the force of contraction.
Bronchospasm: Bronchospasm refers to the sudden, involuntary constriction of the smooth muscles lining the bronchi and bronchioles, leading to narrowing of the airways. This phenomenon is a key feature in various respiratory conditions and can significantly impact breathing function.
Cold Extremities: Cold extremities, also known as peripheral vasoconstriction, refers to the sensation of coldness or decreased temperature in the hands, feet, and other peripheral body parts. This condition is often associated with the use of beta-adrenergic blockers, a class of medications that can affect the body's cardiovascular and autonomic nervous system functions.
Conduction Velocity Reduction: Conduction velocity reduction refers to the slowing down of the speed at which electrical impulses or action potentials travel along nerve fibers or cardiac muscle fibers. This phenomenon can occur due to various physiological or pathological factors and has important implications in the context of beta-adrenergic blockers.
Contractility Reduction: Contractility reduction refers to the decreased ability of the heart muscle to generate force during contraction, leading to a diminished pumping capacity. This term is particularly relevant in the context of Class II: Beta Adrenergic Blockers, as these medications can have a direct impact on cardiac contractility.
Dizziness: Dizziness is a term that describes a range of sensations, including feeling lightheaded, unsteady, or off-balance. It is a common symptom that can be associated with various medical conditions and can significantly impact a person's daily activities and quality of life.
Dyspnea: Dyspnea is the medical term for shortness of breath or difficulty breathing. It is a subjective experience of an uncomfortable or labored breathing sensation that can arise in various medical conditions affecting the respiratory, cardiovascular, or neuromuscular systems.
ECG: An electrocardiogram (ECG) is a medical test that records the electrical activity of the heart over a period of time, providing critical information about heart function and rhythm. It is essential in diagnosing various cardiac conditions, as it highlights irregularities that can be caused by imbalances in electrolytes, the effects of beta adrenergic blockers, and the need for emergency cardiac drugs.
Ectopic Pacemakers: Ectopic pacemakers are abnormal electrical impulse-generating centers within the heart that can take over the heart's natural pacemaker, the sinoatrial (SA) node. These ectopic pacemakers can disrupt the normal heart rhythm and lead to various cardiac arrhythmias.
Esmolol: Esmolol is a short-acting beta-adrenergic blocker used to manage acute dysrhythmias. It works by slowing down the heart rate and reducing myocardial oxygen demand.
Fatigue: Fatigue is a subjective feeling of tiredness, weakness, or lack of energy that can significantly impact an individual's physical and mental performance. In the context of pharmacology, fatigue is an important consideration when evaluating the effects of certain medications, particularly those that interact with the cardiovascular and neurological systems.
Heart Block: Heart block is a type of cardiac conduction disorder where there is an interruption or delay in the electrical impulses traveling from the atria to the ventricles, resulting in an abnormal heart rhythm. This term is particularly relevant in the context of dysrhythmias, as well as the mechanisms of action for various antiarrhythmic drug classes.
Heart Rate Reduction: Heart rate reduction refers to the process of lowering the number of times the heart beats per minute, which can have important implications for cardiovascular health and the management of certain medical conditions. This term is particularly relevant in the context of Class II: Beta Adrenergic Blockers, a group of medications that work by blocking the effects of the sympathetic nervous system on the heart.
Hypotension: Hypotension is a medical condition characterized by an abnormally low blood pressure, where the systolic blood pressure falls below 90 mmHg and the diastolic blood pressure falls below 60 mmHg. This can have significant implications on the body's ability to circulate blood and deliver oxygen and nutrients to vital organs.
Inderal: Inderal is a brand name for propranolol, a non-selective beta-adrenergic blocker used to treat various cardiovascular conditions and anxiety. It works by slowing the heart rate and reducing blood pressure.
Long QT Syndrome: Long QT syndrome is a heart rhythm disorder that can potentially cause fast, chaotic heartbeats, leading to fainting, seizures, and sudden death. It is characterized by a prolonged QT interval, which is the time it takes for the heart's ventricles to recharge between beats, on an electrocardiogram (ECG).
Lopressor: Lopressor is a brand name for metoprolol, a beta-adrenergic blocker used to treat hypertension, angina, and certain heart rhythm disorders. It works by reducing the heart rate and the heart's workload.
Metoprolol: Metoprolol is a beta-adrenergic blocking agent, commonly known as a beta-blocker, that is primarily used to treat various cardiovascular conditions, including hypertension, angina, and certain types of arrhythmias. It works by selectively blocking the beta-1 receptors in the heart, reducing the heart's workload and oxygen demand.
Negative Chronotropy: Negative chronotropy refers to the ability of a substance or agent to decrease the rate or frequency of the heartbeat. It is a key pharmacological effect observed with the use of beta-adrenergic blockers, a class of medications commonly used in the management of cardiovascular conditions.
Negative Dromotropy: Negative dromotropy refers to the slowing or decreasing of the conduction velocity of electrical impulses through the atrioventricular (AV) node of the heart. This effect is associated with the use of certain medications, such as beta-adrenergic blockers, which are classified as Class II antiarrhythmic agents.
Negative Inotropy: Negative inotropy refers to the decreased contractility or force of cardiac muscle contraction. This reduction in the heart's ability to pump blood effectively is a key feature of certain pharmacological agents, particularly those classified as Class II beta-adrenergic blockers.
Non-Selective Beta Receptor Antagonists: Non-selective beta receptor antagonists, also known as non-selective beta blockers, are a class of medications that block the action of both beta-1 and beta-2 adrenergic receptors in the body. These receptors are involved in various physiological processes, and their blockade can lead to therapeutic effects in the management of certain medical conditions.
Palpitations: Palpitations refer to the awareness of an abnormal or irregular heartbeat, often described as a fluttering, pounding, or racing sensation in the chest. This term is particularly relevant in the context of cardiac emergencies, the use of beta-adrenergic blockers, and thyroid disorders.
Propranolol: Propranolol is a beta-adrenergic blocking agent, commonly known as a beta-blocker, that is primarily used to treat a variety of cardiovascular and neurological conditions. It works by blocking the effects of the neurotransmitter norepinephrine, which is responsible for the body\'s fight-or-flight response, making it a versatile medication with applications in the nervous system, migraine treatment, and cardiac dysrhythmia management.
Selective Beta-1 Receptor Antagonists: Selective beta-1 receptor antagonists are a class of medications that specifically target and block the beta-1 adrenergic receptors, which are predominantly found in the heart. This selective action helps manage various cardiovascular conditions by reducing the effects of the sympathetic nervous system on the heart, without significantly impacting the beta-2 receptors found in other organs.
Supraventricular Tachycardias: Supraventricular tachycardias (SVTs) are a group of abnormal heart rhythms that originate from the upper chambers of the heart, known as the atria, and result in a rapid heart rate. These arrhythmias are characterized by an abnormally fast heart rate, typically greater than 100 beats per minute, and can have significant implications for cardiac function and overall health.
Sympathetic Nervous System: The sympathetic nervous system is a division of the autonomic nervous system that is responsible for the body's fight-or-flight response. It prepares the body to respond to perceived threats or stressful situations by increasing heart rate, blood pressure, and breathing rate, while also diverting blood flow away from the digestive system and towards the muscles.
Sympathetic Stimulation: Sympathetic stimulation refers to the activation of the sympathetic nervous system, which is responsible for the body's 'fight-or-flight' response. This physiological process prepares the body to respond to stressful or threatening situations by increasing heart rate, blood pressure, and other functions to enhance the body's ability to cope with the perceived challenge.
Tenormin: Tenormin, also known as atenolol, is a beta-adrenergic blocker commonly used to treat high blood pressure and angina. It works by slowing the heart rate and reducing the heart's workload.
Toprol XL: Toprol XL is an extended-release formulation of metoprolol, a beta-adrenergic blocker used to treat high blood pressure and heart failure. It works by slowing the heart rate and decreasing the workload on the heart.
Ventricular Tachycardias: Ventricular tachycardias are a type of abnormal heart rhythm characterized by a rapid and irregular heartbeat originating from the ventricles, the lower chambers of the heart. These arrhythmias can be life-threatening and require prompt medical attention.
Vital Signs: Vital signs are a set of key physiological measurements that provide important information about an individual's basic body functions. These measurements are crucial in assessing an individual's overall health and well-being, particularly in the context of medical care and treatment.
Wheezing: Wheezing is a high-pitched whistling sound that occurs during breathing, typically when exhaling. It is a common symptom associated with various respiratory conditions that affect the airways, including asthma, chronic obstructive pulmonary disease (COPD), and bronchitis.